Vitor Carvalho Moreno Neves
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Vitor Carvalho Moreno Neves has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Paul Thomas Sharpe
Centre for Craniofacial and Regenerative Biology, Faculty of Dentistry, Oral & Craniofacial Sciences, Guy’s Hospital, King’s College London, London SE1 9RT, UK
7 shared publications Paul Sharpe
Centre for Craniofacial and Regenerative Biology, FoDOCS, King's College London London UK
4 shared publicationsKathy Fung
NIHR BRC Genomics Research Platform, Guy's and St Thomas' NHS Foundation Trust, King's College London School of Medicine London UK
3 shared publicationsPawan Dhami
NIHR BRC Genomics Research Platform, Guy's and St Thomas' NHS Foundation Trust, King's College London School of Medicine London UK
3 shared publicationsCheng Zhang
Science for Life Laboratory KTH – Royal Institute of Technology Stockholm Sweden
2 shared publicationsDhivya Chandrasekaran
Centre for Craniofacial and Regenerative Biology, Dental Institute, Kings College London, London, UK
2 shared publications
Latest Publications
- Open Access
- 18 September 2026
- Published by Springer Nature in British Dental Journal
- p. 1-5
Rethinking systemic adjuncts in periodontitis: a single centre acquisition cost comparison of antimicrobial and non-antimicrobial therapies
Aims To compare National Health Service (NHS) acquisition costs of systemic antimicrobial regimens with emerging non-antimicrobial adjuncts in periodontal therapy and to model potential national financial implications. Methods A secondary acquisition cost comparison analysis was undertaken using three-year prescription data (2021–2024) from a service evaluation at Charles Clifford Dental Hospital. Antibiotic prescriptions were cross-referenced with clinical records to identify those issued for periodontitis. Direct acquisition costs were calculated using Sheffield Teaching Hospitals NHS Foundation Trust pricing. Results Of 643 antibiotic prescriptions, 445 (69.2%) were issued for periodontitis. Azithromycin accounted for 93.5% of periodontal prescriptions, whereas guideline-recommended amoxicillin plus metronidazole (A+M) represented 1.6%. Compared with A+M (£2.81 per course), azithromycin reduced acquisition costs by 55.16%. Non-antimicrobial adjuncts demonstrated substantially greater reductions depending on treatment duration, with metformin 500 mg achieving up to 91.46% reduction. Conclusions Non-antimicrobial systemic adjuncts demonstrate considerable direct cost advantages over traditional antimicrobial regimens. These findings highlight potential economic and antimicrobial stewardship benefits and support the need for formal cost-effectiveness analyses to inform future prescribing guidance.
- 18 September 2026
- Published by Springer Nature in British Dental Journal
- p. 1-5
Open AccessRethinking systemic adjuncts in periodontitis: a single centre acquisition cost comparison of antimicrobial and non-antimicrobial therapies
Aims To compare National Health Service (NHS) acquisition costs of systemic antimicrobial regimens with emerging non-antimicrobial adjuncts in periodontal therapy and to model potential national financial implications. Methods A secondary acquisition cost comparison analysis was undertaken using three-year prescription data (2021–2024) from a service evaluation at Charles Clifford Dental Hospital. Antibiotic prescriptions were cross-referenced with clinical records to identify those issued for periodontitis. Direct acquisition costs were calculated using Sheffield Teaching Hospitals NHS Foundation Trust pricing. Results Of 643 antibiotic prescriptions, 445 (69.2%) were issued for periodontitis. Azithromycin accounted for 93.5% of periodontal prescriptions, whereas guideline-recommended amoxicillin plus metronidazole (A+M) represented 1.6%. Compared with A+M (£2.81 per course), azithromycin reduced acquisition costs by 55.16%. Non-antimicrobial adjuncts demonstrated substantially greater reductions depending on treatment duration, with metformin 500 mg achieving up to 91.46% reduction. Conclusions Non-antimicrobial systemic adjuncts demonstrate considerable direct cost advantages over traditional antimicrobial regimens. These findings highlight potential economic and antimicrobial stewardship benefits and support the need for formal cost-effectiveness analyses to inform future prescribing guidance.
- Open Access
- 17 July 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 6537
Embryonic and postnatal macrophages are necessary for proper tooth development and homeostasis
The role of macrophages in teeth, beyond their function in innate immunity, remains unexplored. This study demonstrates that macrophages populate dental tissues during early development and increase in number during pre-eruptive stages postnatally. In continuously growing teeth, they are associated with epithelial and mesenchymal stem cell niches throughout lifetime. To investigate their role in development, we genetically disrupt macrophage migration using neural-crest specific Wnt1 Cre /Csf1 fl/fl and general Csf1R knockout mouse models. This results in abnormal dentin and enamel deposition, eruption defects, early tooth mispatterning, and impaired osteogenesis. Notably, the phenotype is partially rescued via bone marrow transplantation. In addition, the short-term pharmacological depletion of macrophages in wildtype adult mice causes striking disintegration of both dentin and enamel in the apical part of continuously-growing teeth, which is restored after withdrawal of clodronate. Following treatment, macrophages rapidly repopulate dental tissue and the presence of M2 reparative state phenotype is observed by single-cell RNA-seq analysis. Overall, our findings reveal essential role of macrophages in the dental development and patterning of both mesenchymal and epithelial tooth compartments. This previously unrecognized role of macrophages in teeth is reminiscent of their function in complex tissue regeneration and requires future studies to dissect precise cellular and molecular mechanisms.
- 17 July 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 6537
Open AccessEmbryonic and postnatal macrophages are necessary for proper tooth development and homeostasis
The role of macrophages in teeth, beyond their function in innate immunity, remains unexplored. This study demonstrates that macrophages populate dental tissues during early development and increase in number during pre-eruptive stages postnatally. In continuously growing teeth, they are associated with epithelial and mesenchymal stem cell niches throughout lifetime. To investigate their role in development, we genetically disrupt macrophage migration using neural-crest specific Wnt1 Cre /Csf1 fl/fl and general Csf1R knockout mouse models. This results in abnormal dentin and enamel deposition, eruption defects, early tooth mispatterning, and impaired osteogenesis. Notably, the phenotype is partially rescued via bone marrow transplantation. In addition, the short-term pharmacological depletion of macrophages in wildtype adult mice causes striking disintegration of both dentin and enamel in the apical part of continuously-growing teeth, which is restored after withdrawal of clodronate. Following treatment, macrophages rapidly repopulate dental tissue and the presence of M2 reparative state phenotype is observed by single-cell RNA-seq analysis. Overall, our findings reveal essential role of macrophages in the dental development and patterning of both mesenchymal and epithelial tooth compartments. This previously unrecognized role of macrophages in teeth is reminiscent of their function in complex tissue regeneration and requires future studies to dissect precise cellular and molecular mechanisms.
- Open Access
- 7 October 2025
- Published by Wiley in Journal of Clinical Periodontology
- Vol. 53 (2) , 308-320
Characterising the Periodontal Granulation Tissue Using scRNAseq
Aim: To investigate the cellular composition and molecular mechanisms of periodontal granulation tissue formation using single‐cell RNA sequencing (scRNA‐seq), aiming to enhance the understanding of periodontal disease pathogenesis and identify potential targets for regenerative therapies. Materials and Methods: Granulation tissue samples were collected from patients undergoing periodontal surgery ( n = 3). Fresh tissues were processed into single‐cell suspensions and subjected to scRNA‐seq. The data were integrated and compared with existing datasets from healthy gingiva and periodontal ligament. Computational analyses were performed and validated through immunofluorescence staining. Results: Ten distinct cell clusters were identified across the samples. Granulation tissue exhibited a higher abundance of immune cells compared to healthy tissues. A novel endothelial cell subpopulation, exclusive to granulation tissue, was discovered and characterised by NOTCH3 expression and involvement in ossification pathways. Additionally, granulation tissue fibroblast subpopulations demonstrated a progenitor‐like state, characterised by extracellular matrix reorganisation and low differentiation, similar to cancer‐associated fibroblasts. Conclusion: This study identified a novel endothelial subpopulation offering new insights into the disease's pathogenesis and presenting potential targets for regenerative therapies. These findings will help advance the understanding of periodontal disease granulation tissue formation and provide information for the development of materials to modulate specific cellular pathways to improve periodontal disease management.
- 7 October 2025
- Published by Wiley in Journal of Clinical Periodontology
- Vol. 53 (2) , 308-320
Open AccessCharacterising the Periodontal Granulation Tissue Using scRNAseq
Aim: To investigate the cellular composition and molecular mechanisms of periodontal granulation tissue formation using single‐cell RNA sequencing (scRNA‐seq), aiming to enhance the understanding of periodontal disease pathogenesis and identify potential targets for regenerative therapies. Materials and Methods: Granulation tissue samples were collected from patients undergoing periodontal surgery ( n = 3). Fresh tissues were processed into single‐cell suspensions and subjected to scRNA‐seq. The data were integrated and compared with existing datasets from healthy gingiva and periodontal ligament. Computational analyses were performed and validated through immunofluorescence staining. Results: Ten distinct cell clusters were identified across the samples. Granulation tissue exhibited a higher abundance of immune cells compared to healthy tissues. A novel endothelial cell subpopulation, exclusive to granulation tissue, was discovered and characterised by NOTCH3 expression and involvement in ossification pathways. Additionally, granulation tissue fibroblast subpopulations demonstrated a progenitor‐like state, characterised by extracellular matrix reorganisation and low differentiation, similar to cancer‐associated fibroblasts. Conclusion: This study identified a novel endothelial subpopulation offering new insights into the disease's pathogenesis and presenting potential targets for regenerative therapies. These findings will help advance the understanding of periodontal disease granulation tissue formation and provide information for the development of materials to modulate specific cellular pathways to improve periodontal disease management.
- Open Access
Characterising the periodontal granulation tissue using scRNAseq
Aims Our research investigated the cellular composition and molecular mechanisms of periodontal granulation tissue using single-cell RNA sequencing (scRNA-seq), aiming to enhance the understanding of periodontal disease pathogenesis and identify potential targets for regenerative therapies. Materials and Methods Granulation tissue samples were collected from patients undergoing periodontal surgery. Fresh tissues were processed into single-cell suspensions and subjected to scRNA-seq. The data were integrated with existing datasets from healthy gingiva and periodontal ligament. Computational analyses were performed, and validation through immunofluorescence staining. Results Ten distinct cell clusters were identified across the samples. Granulation tissue exhibited a higher abundance of immune cells compared to healthy tissues. A novel endothelial cell subpopulation, exclusive to granulation tissue, was discovered, characterized by NOTCH3 expression and involvement in ossification pathways. Additionally, granulation tissue Fibroblast subpopulations demonstrated a progenitor-like state, characterized by extracellular matrix reorganization and low differentiation, similar to cancer-associated fibroblasts. Conclusion(s) This study advances the understanding of periodontal disease by characterizing key regulatory cell populations within granulation tissue. The identification of the novel endothelial subpopulation offers new insights into the disease’s pathogenesis and presents potential targets for regenerative therapies. These findings suggest opportunities for developing biomaterials that modulate specific cellular pathways to improve periodontal disease treatment.
Open AccessCharacterising the periodontal granulation tissue using scRNAseq
Aims Our research investigated the cellular composition and molecular mechanisms of periodontal granulation tissue using single-cell RNA sequencing (scRNA-seq), aiming to enhance the understanding of periodontal disease pathogenesis and identify potential targets for regenerative therapies. Materials and Methods Granulation tissue samples were collected from patients undergoing periodontal surgery. Fresh tissues were processed into single-cell suspensions and subjected to scRNA-seq. The data were integrated with existing datasets from healthy gingiva and periodontal ligament. Computational analyses were performed, and validation through immunofluorescence staining. Results Ten distinct cell clusters were identified across the samples. Granulation tissue exhibited a higher abundance of immune cells compared to healthy tissues. A novel endothelial cell subpopulation, exclusive to granulation tissue, was discovered, characterized by NOTCH3 expression and involvement in ossification pathways. Additionally, granulation tissue Fibroblast subpopulations demonstrated a progenitor-like state, characterized by extracellular matrix reorganization and low differentiation, similar to cancer-associated fibroblasts. Conclusion(s) This study advances the understanding of periodontal disease by characterizing key regulatory cell populations within granulation tissue. The identification of the novel endothelial subpopulation offers new insights into the disease’s pathogenesis and presents potential targets for regenerative therapies. These findings suggest opportunities for developing biomaterials that modulate specific cellular pathways to improve periodontal disease treatment.
- Open Access
- 1 July 2024
- Published by Frontiers Media SA in Frontiers in Dental Medicine
- Vol. 5, 1415960
Periodontal ageing and its management via pharmacological glucose modulation
Periodontal disease (PD), a widespread non-communicable disease, affects over 90% of the global population with no known cure. Current management strategies focus on the stabilisation of disease progression, which is successfully achieved to a limited extent. Yet the never-ending battle between bacteria and the gingiva involves a complex interplay between genetic, microbial and environmental factors, demanding innovative approaches to improve the prevention and stabilisation of this disease. Glucose is the body's source of energy and research has shown that dysregulation of the glucose metabolism impacts PD establishment and progression, as well as the development of systemic non-communicable diseases. Metformin, a drug known for its efficacy in diabetes treatment via controlling glucose metabolism, also demonstrated cardioprotective effects, increased longevity, and anti-inflammatory properties. Metformin has been used in gel format in clinical trials for non-surgical treatment of PD, however, its systemic use in normoglycemic individuals with PD is less explored. A recent study presented compelling evidence of metformin's preventive potential, impacting PD and markers of systemic health involved in metabolic health linked to improvement of lifespan. Therefore, this review discusses the aspects of ageing as a concept in the periodontium and the potential benefits of modulating glucose metabolism through metformin to prevent PD, indirectly preventing systemic conditions involved in multi-morbidity, addressing a critical gap in current management. It also examines the choice between implementation of behaviour change and/or medication as a strategy to add to current oral hygiene strategies. Finally, it discusses the ethical implications of prescribing systemic medication in dentistry.
- 1 July 2024
- Published by Frontiers Media SA in Frontiers in Dental Medicine
- Vol. 5, 1415960
Open AccessPeriodontal ageing and its management via pharmacological glucose modulation
Periodontal disease (PD), a widespread non-communicable disease, affects over 90% of the global population with no known cure. Current management strategies focus on the stabilisation of disease progression, which is successfully achieved to a limited extent. Yet the never-ending battle between bacteria and the gingiva involves a complex interplay between genetic, microbial and environmental factors, demanding innovative approaches to improve the prevention and stabilisation of this disease. Glucose is the body's source of energy and research has shown that dysregulation of the glucose metabolism impacts PD establishment and progression, as well as the development of systemic non-communicable diseases. Metformin, a drug known for its efficacy in diabetes treatment via controlling glucose metabolism, also demonstrated cardioprotective effects, increased longevity, and anti-inflammatory properties. Metformin has been used in gel format in clinical trials for non-surgical treatment of PD, however, its systemic use in normoglycemic individuals with PD is less explored. A recent study presented compelling evidence of metformin's preventive potential, impacting PD and markers of systemic health involved in metabolic health linked to improvement of lifespan. Therefore, this review discusses the aspects of ageing as a concept in the periodontium and the potential benefits of modulating glucose metabolism through metformin to prevent PD, indirectly preventing systemic conditions involved in multi-morbidity, addressing a critical gap in current management. It also examines the choice between implementation of behaviour change and/or medication as a strategy to add to current oral hygiene strategies. Finally, it discusses the ethical implications of prescribing systemic medication in dentistry.
- Open Access
- 10 October 2023
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 21 (1) , 1-18
Repurposing Metformin for periodontal disease management as a form of oral-systemic preventive medicine
Background: Despite the improvements in treatment over the last decades, periodontal disease (PD) affects millions of people around the world and the only treatment available is based on controlling microbial load. Diabetes is known to increase the risk of PD establishment and progression, and recently, glucose metabolism modulation by pharmaceutical or dietarian means has been emphasised as a significant modulator of non-communicable disease development. Methods: The impact of pharmaceutically controlling glucose metabolism in non-diabetic animals and humans (REBEC, UTN code: U1111-1276-1942) was investigated by repurposing Metformin, as a mean to manage periodontal disease and its associated systemic risk factors. Results: We found that glucose metabolism control via use of Metformin aimed at PD management resulted in significant prevention of bone loss during induced periodontal disease and age-related bone loss in vivo. Metformin also influenced the bacterial species present in the oral environment and impacted the metabolic epithelial and stromal responses to bacterial dysbiosis at a single cell level. Systemically, Metformin controlled blood glucose levels and age-related weight gain when used long-term. Translationally, our pilot randomized control trial indicated that systemic Metformin was safe to use in non-diabetic patients and affected the periodontal tissues. During the medication window, patients showed stable levels of systemic blood glucose, lower circulating hsCRP and lower insulin levels after periodontal treatment when compared to placebo. Finally, patients treated with Metformin had improved periodontal parameters when compared to placebo treated patients. Conclusion: This is the first study to demonstrate that systemic interventions using Metformin in non-diabetic individuals aimed at PD prevention have oral-systemic effects constituting a possible novel form of preventive medicine for oral-systemic disease management.
- 10 October 2023
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 21 (1) , 1-18
Open AccessRepurposing Metformin for periodontal disease management as a form of oral-systemic preventive medicine
Background: Despite the improvements in treatment over the last decades, periodontal disease (PD) affects millions of people around the world and the only treatment available is based on controlling microbial load. Diabetes is known to increase the risk of PD establishment and progression, and recently, glucose metabolism modulation by pharmaceutical or dietarian means has been emphasised as a significant modulator of non-communicable disease development. Methods: The impact of pharmaceutically controlling glucose metabolism in non-diabetic animals and humans (REBEC, UTN code: U1111-1276-1942) was investigated by repurposing Metformin, as a mean to manage periodontal disease and its associated systemic risk factors. Results: We found that glucose metabolism control via use of Metformin aimed at PD management resulted in significant prevention of bone loss during induced periodontal disease and age-related bone loss in vivo. Metformin also influenced the bacterial species present in the oral environment and impacted the metabolic epithelial and stromal responses to bacterial dysbiosis at a single cell level. Systemically, Metformin controlled blood glucose levels and age-related weight gain when used long-term. Translationally, our pilot randomized control trial indicated that systemic Metformin was safe to use in non-diabetic patients and affected the periodontal tissues. During the medication window, patients showed stable levels of systemic blood glucose, lower circulating hsCRP and lower insulin levels after periodontal treatment when compared to placebo. Finally, patients treated with Metformin had improved periodontal parameters when compared to placebo treated patients. Conclusion: This is the first study to demonstrate that systemic interventions using Metformin in non-diabetic individuals aimed at PD prevention have oral-systemic effects constituting a possible novel form of preventive medicine for oral-systemic disease management.
- 10 September 2021
- Published by Springer Nature in British Dental Journal
- Vol. 231 (5) , 277-280
Beyond oral hygiene, are capacity-altering, biologically based interventions within the moral domain of dentistry?
Oral diseases such as dental caries (DC) and periodontitis are widely prevalent, and existing approaches to managing these conditions have only a limited effect. Accordingly, there is growing interest in the development of novel biological interventions (including, among others, CRISPR-Cas9) that might, in the future, be used to prevent the development of or cure these conditions. However, in addition to familiar concerns about using biological interventions in children who cannot provide valid consent, it is not clear whether the provision of these interventions would fall within the proper domain of dentistry. In this opinion paper, we defend the view that the provision of reasonably safe and effective novel biological interventions aimed at preventing DC and periodontitis should be understood to fall within the proper domain of dentistry. To do so, we first argue that their use would be consistent with existing practice in dentistry. We then argue that: i) they may substantially increase the recipient's wellbeing and future autonomy; and ii) that their use could constitute a form of indirect preventative medicine by addressing a threat to systemic health.
- 10 September 2021
- Published by Springer Nature in British Dental Journal
- Vol. 231 (5) , 277-280
Beyond oral hygiene, are capacity-altering, biologically based interventions within the moral domain of dentistry?
Oral diseases such as dental caries (DC) and periodontitis are widely prevalent, and existing approaches to managing these conditions have only a limited effect. Accordingly, there is growing interest in the development of novel biological interventions (including, among others, CRISPR-Cas9) that might, in the future, be used to prevent the development of or cure these conditions. However, in addition to familiar concerns about using biological interventions in children who cannot provide valid consent, it is not clear whether the provision of these interventions would fall within the proper domain of dentistry. In this opinion paper, we defend the view that the provision of reasonably safe and effective novel biological interventions aimed at preventing DC and periodontitis should be understood to fall within the proper domain of dentistry. To do so, we first argue that their use would be consistent with existing practice in dentistry. We then argue that: i) they may substantially increase the recipient's wellbeing and future autonomy; and ii) that their use could constitute a form of indirect preventative medicine by addressing a threat to systemic health.
- 24 March 2021
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 16 (4) , 343-345
Advances in Regenerative Dentistry; Building with Biology
- 24 March 2021
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 16 (4) , 343-345
Advances in Regenerative Dentistry; Building with Biology
- Open Access
- 10 March 2021
- Published by Frontiers Media SA in Frontiers in Dental Medicine
- Vol. 2
A Pilot Epidemiological Exploration of Regenerative Dentistry From the Perspective of Active Clinicians Working in the UK
Innovation has always been part of dentistry and with that comes thinking outside the box to produce guidelines for implementation of new approaches. Regenerative dentistry (RD) is a young specialty within the profession, which gathers knowledge from stem cells, molecular biology, and tissue and material engineering to produce and apply novel biologically based therapies. Since RD is an emerging branch of dentistry, it is not yet understood whether active clinicians are aware of this field and know exactly what it does. The aim of this study is to explore the awareness, understanding, and beliefs about RD of active dentists. A random selection of active dentists in the UK was approached via e-mail and face-to-face and asked to fill in a questionnaire. A total of 45 responses were received and analyzed. The results showed that active dentists in the UK are aware of the field but are not prepared to apply personalized biologically based therapies and feel a desire to educate themselves about RD further. Also, the results shine a light on the opportunities for regulatory and educational bodies to work together to prepare the clinicians for this novel field. Our research suggests that active dentists are ill-prepared for an era of personalized biologically based dental treatments. Further thinking of how to implement basic and more advanced biological knowledge and their application in dentistry is needed, and suggestions are made here.
- 10 March 2021
- Published by Frontiers Media SA in Frontiers in Dental Medicine
- Vol. 2
Open AccessA Pilot Epidemiological Exploration of Regenerative Dentistry From the Perspective of Active Clinicians Working in the UK
Innovation has always been part of dentistry and with that comes thinking outside the box to produce guidelines for implementation of new approaches. Regenerative dentistry (RD) is a young specialty within the profession, which gathers knowledge from stem cells, molecular biology, and tissue and material engineering to produce and apply novel biologically based therapies. Since RD is an emerging branch of dentistry, it is not yet understood whether active clinicians are aware of this field and know exactly what it does. The aim of this study is to explore the awareness, understanding, and beliefs about RD of active dentists. A random selection of active dentists in the UK was approached via e-mail and face-to-face and asked to fill in a questionnaire. A total of 45 responses were received and analyzed. The results showed that active dentists in the UK are aware of the field but are not prepared to apply personalized biologically based therapies and feel a desire to educate themselves about RD further. Also, the results shine a light on the opportunities for regulatory and educational bodies to work together to prepare the clinicians for this novel field. Our research suggests that active dentists are ill-prepared for an era of personalized biologically based dental treatments. Further thinking of how to implement basic and more advanced biological knowledge and their application in dentistry is needed, and suggestions are made here.
- Top Cited PapersOpen Access
- 23 September 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-18
Dental cell type atlas reveals stem and differentiated cell types in mouse and human teeth
Understanding cell types and mechanisms of dental growth is essential for reconstruction and engineering of teeth. Therefore, we investigated cellular composition of growing and non-growing mouse and human teeth. As a result, we report an unappreciated cellular complexity of the continuously-growing mouse incisor, which suggests a coherent model of cell dynamics enabling unarrested growth. This model relies on spatially-restricted stem, progenitor and differentiated populations in the epithelial and mesenchymal compartments underlying the coordinated expansion of two major branches of pulpal cells and diverse epithelial subtypes. Further comparisons of human and mouse teeth yield both parallelisms and differences in tissue heterogeneity and highlight the specifics behind growing and non-growing modes. Despite being similar at a coarse level, mouse and human teeth reveal molecular differences and species-specific cell subtypes suggesting possible evolutionary divergence. Overall, here we provide an atlas of human and mouse teeth with a focus on growth and differentiation.
- 23 September 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-18
Top Cited PapersOpen AccessDental cell type atlas reveals stem and differentiated cell types in mouse and human teeth
Understanding cell types and mechanisms of dental growth is essential for reconstruction and engineering of teeth. Therefore, we investigated cellular composition of growing and non-growing mouse and human teeth. As a result, we report an unappreciated cellular complexity of the continuously-growing mouse incisor, which suggests a coherent model of cell dynamics enabling unarrested growth. This model relies on spatially-restricted stem, progenitor and differentiated populations in the epithelial and mesenchymal compartments underlying the coordinated expansion of two major branches of pulpal cells and diverse epithelial subtypes. Further comparisons of human and mouse teeth yield both parallelisms and differences in tissue heterogeneity and highlight the specifics behind growing and non-growing modes. Despite being similar at a coarse level, mouse and human teeth reveal molecular differences and species-specific cell subtypes suggesting possible evolutionary divergence. Overall, here we provide an atlas of human and mouse teeth with a focus on growth and differentiation.